Vineet Laboratories Corrects FY2026 Results Approval Date

The Board of Directors meeting was held on August 25, 2026, from 3:00 PM to 6:30 PM and approved:

Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026
Audited Standalone Financial Statement for the financial year ended March 31, 2026 along with Audit Report

Assets:

Total Assets: ₹12,478.34 lakhs (vs. ₹9,454.01 lakhs in FY2025)
Non-current assets: ₹2,595.42 lakhs (including Property, plant and equipment: ₹2,424.06 lakhs)
Current assets: ₹9,882.92 lakhs (including Inventories: ₹6,409.07 lakhs, Cash and cash equivalents: ₹1,669.52 lakhs)

Equity and Liabilities:

Total Equity: ₹4,560.19 lakhs (vs. ₹1,464.76 lakhs in FY2025)
Equity share capital: ₹1,920.63 lakhs
Other equity: ₹2,639.57 lakhs
Total Liabilities: ₹7,918.14 lakhs
Non-current liabilities: ₹1,189.66 lakhs (including Borrowings: ₹1,020.66 lakhs)
Current liabilities: ₹6,728.48 lakhs (including Borrowings: ₹3,511.88 lakhs)

Profit before tax: ₹128.27 lakhs (vs. loss of ₹2,077.55 lakhs in FY2025)
Net cash used in operating activities: ₹(1,203.19) lakhs
Net cash used in investing activities: ₹(111.00) lakhs
Net cash from financing activities: ₹2,974.34 lakhs (including Issuance of shares: ₹2,908.18 lakhs)
Net change in cash and cash equivalents: ₹1,660.15 lakhs
Cash and cash equivalents at year-end: ₹1,669.52 lakhs (includes Cash on hand: ₹26.15 lakhs, Bank balances: ₹1,643.37 lakhs)

| Particulars | Details |

| Outstanding long-term Borrowings at start of FY | ₹39.09 Crores |

| Outstanding long-term Borrowings at end of FY | ₹35.29 Crores |

| Highest credit rating | Not Available |

| Incremental borrowing during year | Nil |

| Borrowings via debt securities | Nil |

The company confirmed it is not a Large Corporate as per SEBI Operational Circular dated April 13, 2022.